Majestic Corporation 接近美国OTCQB名单;Gentral看到狗老化试验的积极结果。 Majestic Corp nears U.S. OTCQB listing; Genflow sees positive results in dog ageing trial.

Majestic Corporation Plc已接近获得批准,可以列入美国OTCQB市场,这将改善美国投资者的准入,支持其可持续回收的全球扩张。 Majestic Corporation Plc is close to gaining approval to list on the U.S. OTCQB Market, which would improve access for American investors and support its global expansion in sustainable recycling. 同时,Genflow生物科学组织报告,在使用人类基因疗法进行狗老化试验时,在安全方面有一个里程碑,第二剂后没有观察到对老年青豆产生任何不利影响。 Meanwhile, Genflow Biosciences reported a safety milestone in its dog ageing trial using a human-derived gene therapy, with no adverse effects observed after the second dose in elderly beagles. 该试验定于2026年1月结束,目的是评估该疗法通过强化细胞修复减缓老化的潜力。 The trial, set to end in January 2026, aims to assess the therapy’s potential to slow ageing through enhanced cellular repair. 在其他事态发展中,SoftBank正在寻求一笔50亿美元的贷款,将Arm Holdings股份作为促进OpenAI投资的抵押品,而Discoord则调查通过受损害的第三方供应商影响到多达70 000名用户的一个数据违规事件。 In other developments, SoftBank is seeking a $5 billion loan using Arm Holdings shares as collateral to boost investments in OpenAI, while Discord investigates a data breach affecting up to 70,000 users via a compromised third-party vendor. 随着黄金价格的下跌,FTSE 100下降。 The FTSE 100 declined as gold prices eased.